Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
190M
-
Shares change
-
+16M
-
Total reported value, excl. options
-
$5.69B
-
Value change
-
+$497M
-
Put/Call ratio
-
0.58
-
Number of buys
-
212
-
Number of sells
-
-69
-
Price
-
$29.95
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q1 2020
328 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q1 2020.
Moderna, Inc. - COMMON STOCK (MRNA) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 190M shares
of 385M outstanding shares and own 49.42% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (50.9M shares), FMR LLC (24.8M shares), VANGUARD GROUP INC (20.6M shares), BlackRock Inc. (12.4M shares), Theleme Partners LLP (8.93M shares), STATE STREET CORP (5.5M shares), MORGAN STANLEY (5.49M shares), Invesco Ltd. (4.64M shares), Bellevue Group AG (3.95M shares), and BAILLIE GIFFORD & CO (3.56M shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.